260 related articles for article (PubMed ID: 15731916)
21. [Potential drug interactions in the treatment of elderly patients with multiple morbidity].
Kruse W; Köhler J; Oster P; Schlierf G
Z Gerontol; 1988; 21(3):164-8. PubMed ID: 3407287
[TBL] [Abstract][Full Text] [Related]
22. Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria.
Gallagher PF; Barry PJ; Ryan C; Hartigan I; O'Mahony D
Age Ageing; 2008 Jan; 37(1):96-101. PubMed ID: 17933759
[TBL] [Abstract][Full Text] [Related]
23. Drug-drug interactions at hospital admission in geriatric patients in a single facility: a retrospective study.
Sánchez-Arenas R; Sánchez-García S; García-Peña C; García-Gonzàlez JJ; Rivera-García BE; Juárez-Cedillo T
Int J Clin Pharmacol Ther; 2012 Jun; 50(6):426-30. PubMed ID: 22541743
[TBL] [Abstract][Full Text] [Related]
24. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions.
Yu DT; Peterson JF; Seger DL; Gerth WC; Bates DW
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):755-67. PubMed ID: 15654717
[TBL] [Abstract][Full Text] [Related]
25. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use.
Page RL; Ruscin JM
Am J Geriatr Pharmacother; 2006 Dec; 4(4):297-305. PubMed ID: 17296535
[TBL] [Abstract][Full Text] [Related]
26. [Potential and real drug interactions in critical care patients].
Sierra P; Castillo J; Gómez M; Sorribes V; Monterde J; Castaño J
Rev Esp Anestesiol Reanim; 1997 Dec; 44(10):383-7. PubMed ID: 9494361
[TBL] [Abstract][Full Text] [Related]
27. Potential drug interactions with H2-receptor antagonists in intensive care unit patients.
Monaghan MS; Falls L; Olsen KM
Hosp Pharm; 1993 Apr; 28(4):296-7, 300-1, 305 passim. PubMed ID: 10136586
[TBL] [Abstract][Full Text] [Related]
28. Quality of pharmacotherapy and outcomes for older veterans discharged from the emergency department.
Hastings SN; Schmader KE; Sloane RJ; Weinberger M; Pieper CF; Goldberg KC; Oddone EZ
J Am Geriatr Soc; 2008 May; 56(5):875-80. PubMed ID: 18341519
[TBL] [Abstract][Full Text] [Related]
29. Use of drugs and adverse reactions in medical inpatients.
Jitapunkul S; Lertkupinit C; Jongsitimahakul A; Suteparuk S
J Med Assoc Thai; 1997 Oct; 80(10):636-41. PubMed ID: 10904566
[TBL] [Abstract][Full Text] [Related]
30. Comparison of drug-related problems in different patient groups.
Viktil KK; Blix HS; Reikvam A; Moger TA; Hjemaas BJ; Walseth EK; Vraalsen TF; Pretsch P; Jorgensen F
Ann Pharmacother; 2004 Jun; 38(6):942-8. PubMed ID: 15069168
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for potential drug interactions in general practice.
Bjerrum L; Gonzalez Lopez-Valcarcel B; Petersen G
Eur J Gen Pract; 2008; 14(1):23-9. PubMed ID: 18464169
[TBL] [Abstract][Full Text] [Related]
32. Incidence and contributors to potential drug-drug interactions in hospitalized patients.
Reimche L; Forster AJ; van Walraven C
J Clin Pharmacol; 2011 Jul; 51(7):1043-50. PubMed ID: 20926752
[TBL] [Abstract][Full Text] [Related]
33. Frequency of high-risk use of QT-prolonging medications.
Allen LaPointe NM; Curtis LH; Chan KA; Kramer JM; Lafata JE; Gurwitz JH; Raebel MA; Platt R
Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):361-8. PubMed ID: 16178046
[TBL] [Abstract][Full Text] [Related]
34. Extent of potential drug interactions among patients receiving anti-hypertensive medications.
Sweileh WM; Sawalha AF; Jaradat NA
Saudi Med J; 2005 Apr; 26(4):548-52. PubMed ID: 15900357
[TBL] [Abstract][Full Text] [Related]
35. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
Sokol KC; Knudsen JF; Li MM
J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667
[TBL] [Abstract][Full Text] [Related]
36. Costs of intravenous adverse drug events in academic and nonacademic intensive care units.
Nuckols TK; Paddock SM; Bower AG; Rothschild JM; Fairbanks RJ; Carlson B; Panzer RJ; Hilborne LH
Med Care; 2008 Jan; 46(1):17-24. PubMed ID: 18162851
[TBL] [Abstract][Full Text] [Related]
37. Potential interactions between prescription drugs and complementary and alternative medicines among patients in the emergency department.
Taylor DM; Walsham N; Taylor SE; Wong L
Pharmacotherapy; 2006 May; 26(5):634-40. PubMed ID: 16637793
[TBL] [Abstract][Full Text] [Related]
38. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital in Nepal.
Mallik S; Palaian S; Ojha P; Mishra P
Pak J Pharm Sci; 2007 Jul; 20(3):214-8. PubMed ID: 17545106
[TBL] [Abstract][Full Text] [Related]
39. Clinical drug interactions in outpatients of a university hospital in Thailand.
Janchawee B; Owatranporn T; Mahatthanatrakul W; Chongsuvivatwong V
J Clin Pharm Ther; 2005 Dec; 30(6):583-90. PubMed ID: 16336291
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa.
Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
J Clin Pharm Ther; 2008 Aug; 33(4):393-400. PubMed ID: 18613857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
